KM	Homo sapiens	0.0146	tert-butyloxycarbonyl-Asp(benzyl ester)-Pro-Arg-4-methylcoumaryl-7-amide	*pH 8.3, 37&deg;C
KM	Homo sapiens	0.027	N-alpha-tert-butyloxycarbonyl-Val-Pro-Arg-4-methylcoumaryl-7-amide	*pH 8.3, 37&deg;C
KM	Homo sapiens	0.041	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant K182Q/R184Q, Vmax: 0.058 pmol/min/microgram protein
KM	Homo sapiens	0.0508	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant M220A/K221Q, Vmax: 0.01 pmol/min/microgram protein
KM	Homo sapiens	0.054	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant K51A/R62A/L73A/L76A/F82A, Vmax: 0.085 pmol/min/microgram protein
KM	Homo sapiens	0.074	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant K93Q/F94A, Vmax: 0.147 pmol/min/microgram protein
KM	Homo sapiens	0.083	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant L73A/L76A/F82A, Vmax: 0.053 pmol/min/microgram protein
KM	Homo sapiens	0.103	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant R130Q/R169Q, Vmax: 0.16 pmol/min/microgram protein
KM	Homo sapiens	0.112	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant K124Q/R150Q/F151A/K152Q, Vmax: 0.1 pmol/min/microgram protein
KM	Homo sapiens	0.114	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant D207N/Q219A, Vmax: 0.044 pmol/min/microgram protein
KM	Homo sapiens	0.121	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant V252A/I267A, Vmax: 1.284 pmol/min/microgram protein
KM	Homo sapiens	0.122	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant R150Q/F151A/K152Q, Vmax: 0.087 pmol/min/microgram protein
KM	Homo sapiens	0.128	methylsulfonyl-D-Phe-Gly-Arg-4-methylcoumaryl-7-amide	*pH 8.3, 37&deg;C
KM	Homo sapiens	0.14	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant D26N/K27Q/F29A/Q31A, Vmax: 0.834 pmol/min/microgram protein
KM	Homo sapiens	0.149	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*wild-type, Vmax: 0.09 pmol/min/microgram protein
KM	Homo sapiens	0.168	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant F94A/K182Q/R184Q, Vmax: 0.672 pmol/min/microgram protein
KM	Homo sapiens	0.177	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant K51A/R62A, Vmax: 0.373 pmol/min/microgram protein
KM	Homo sapiens	0.195	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant D207N/Q219A/M220A/K221Q, Vmax: 0.032 pmol/min/microgram protein
KM	Homo sapiens	0.199	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant F29A/Q31A, Vmax: 0.854 pmol/min/microgram protein
KM	Homo sapiens	0.203	tert-butyloxycarbonyl-Asp(benzyl)-Pro-Arg-7-amido-4-methylcoumarin	*mutant V212A/L236A, Vmax: 2.126 pmol/min/microgram protein
MW	Homo sapiens	-999	*	*mutant protein reveals a slightly different migration pattern during electrophoresis under reducing conditions, due to proximity of the mutation to a cysteine residue
MW	Homo sapiens	892	*	*Man3GlcNAc2 core, deduced molecular weight of N-linked glycan structure
MW	Homo sapiens	1622	*	*A2G2, deduced molecular weight of N-linked glycan structure
MW	Homo sapiens	1824	*	*A3G2, deduced molecular weight of N-linked glycan structure
MW	Homo sapiens	1912	*	*A2G2S1, deduced molecular weight of N-linked glycan structure
MW	Homo sapiens	2115	*	*A3G2S1, deduced molecular weight of N-linked glycan structure
MW	Homo sapiens	2202	*	*A2G2S2, deduced molecular weight of N-linked glycan structure
MW	Homo sapiens	2277	*	*A3G3S1, deduced molecular weight of N-linked glycan structure
MW	Homo sapiens	2405	*	*A3G2S2, deduced molecular weight of N-linked glycan structure
MW	Homo sapiens	2567	*	*A3G3S2, deduced molecular weight of N-linked glycan structure
MW	Homo sapiens	3569	*	*approximate reduction of molecular weight for the heavy chain after partial deglycosylation of native protein with ABS, BTG and GuH exoglycosidases
MW	Homo sapiens	5632	*	*approximate reduction of molecular weight for the light chain after partial deglycosylation of native protein with ABS, BTG and GuH exoglycosidases
MW	Homo sapiens	9201	*	*approximate reduction of molecular weight for total molecule of factor I after partial deglycosylation of native protein with ABS, BTG and GuH exoglycosidases
MW	Mus musculus	27000	*	*1 * 27000 + 1 * 37500, calculation from nucleotide sequence
MW	Homo sapiens	27590	*	*calculated for non-glycosylated light chain, estimated basing upon results of the N-linked glycan analysis
MW	Rattus norvegicus	28500	*	*1 * 28500 + 1 * 38000, calculation from nucleotide sequence
MW	Homo sapiens	30270	*	*estimated for light chain of a partially deglycosylated factor I bearing a single N-linked Man3GlcNAc2 core structure at each glycosylation site
MW	Homo sapiens	35290	*	*calculated for non-glycosylated heavy chain, estimated basing upon results of the N-linked glycan analysis
MW	Homo sapiens	35900	*	*native light chain, estimated basing upon results from the N-linked glycan analysis
MW	Homo sapiens	37000	*	*light chain of
MW	Mus musculus	37500	*	*1 * 27000 + 1 * 37500, calculation from nucleotide sequence
MW	Homo sapiens	37960	*	*estimated for heavy chain of a partially deglycosylated factor I bearing a single N-linked Man3GlcNAc2 core structure at each glycosylation site
MW	Homo sapiens	38000	*	*SP-domain-form, SDS-PAGE
MW	Homo sapiens	38000	*	*light chain of
MW	Homo sapiens	38000	*	*Western blotting, light chain of CFI under reducing conditions
MW	Homo sapiens	38000	*	*light-chain, Western blot, reducing condition
MW	Homo sapiens	38000	*	*1 * 50000 + 1 * 38000, SDS-PAGE, the enzyme is proteolytically processed into the heavy and the light chain that remain covalently linked by a disulfide bond, domains structure overview
MW	Homo sapiens	38000	*	*1 * 38000 + 1 * 50000, non-catalytic 50000 Da subunit is disulfide-linked to the 38000 Da catalytic subunit
MW	Rattus norvegicus	38000	*	*1 * 28500 + 1 * 38000, calculation from nucleotide sequence
MW	Homo sapiens	41530	*	*native heavy chain, estimated basing upon results from the N-linked glycan analysis
MW	Homo sapiens	50000	*	*heavy chain of
MW	Homo sapiens	50000	*	*heavy chain, indicative of processing
MW	Homo sapiens	50000	*	*heavy chain of
MW	Homo sapiens	50000	*	*heavy chain, indicative of processing
MW	Homo sapiens	50000	*	*Western blotting, truncated Q336x mutant under non-reducing conditions and heavy chain of CFI under reducing conditions
MW	Homo sapiens	50000	*	*heavy-chain, Western blot, reducing condition
MW	Homo sapiens	50000	*	*1 * 50000 + 1 * 38000, SDS-PAGE, the enzyme is proteolytically processed into the heavy and the light chain that remain covalently linked by a disulfide bond, domains structure overview
MW	Homo sapiens	50000	*	*1 * 38000 + 1 * 50000, non-catalytic 50000 Da subunit is disulfide-linked to the 38000 Da catalytic subunit
MW	Homo sapiens	58000	*	*SDS-PAGE
MW	Homo sapiens	62880	*	*total calculated molecular weight for non-glycosylated factor I, estimated basing upon results of the N-linked glycan analysis
MW	Homo sapiens	66000	*	*nonglycosylated proenzyme
MW	Homo sapiens	68230	*	*estimated for total protein bearing a single N-linked Man3GlcNAc2 core structure at each glycosylation site
MW	Homo sapiens	75000	*	*x * 75000, SDS-PAGE
MW	Homo sapiens	77430	*	*deduced for total protein of the native factor I basing upon results from the N-linked glycan analysis
MW	Homo sapiens	88000	*	*fI, SDS-PAGE
MW	Mus musculus	88000	*	*SDS-PAGE, nonreducing conditions, detection of murine complement factor I by using a crossreactive polyclonal goat antibody against human complement factor I
MW	Homo sapiens	88000	*	*non-reduced form, SDS-PAGE; reduced form, RRKR-linker peptide not cleaved, corresponds to pro-complemement factor I
MW	Homo sapiens	88000	*	*SDS-PAGE
MW	Homo sapiens	88000	*	*non-reduced CFI proteins, SDS-PAGE; reduced form, RRKR-linker peptide not cleaved, corresponds to pro-complement factor I
MW	Homo sapiens	88000	*	*Western blotting, wild-type and the Q232K, C237Y and S250L mutants under non-reducing conditions
MW	Homo sapiens	88000	*	*coimmunoprecipitation analysis
MW	Homo sapiens	88000	*	*Western blotting
MW	Homo sapiens	88000	*	*SDS-PAGE, non-reducing conditions; Western blot, non-reducing condition
MW	Homo sapiens	88000	*	*mature enzyme
MW	Homo sapiens	88000	*	*sucrose density gradient centrifugation
MW	Homo sapiens	90000	*	*unprocessed, under reducing conditions, SDS-PAGE
MW	Homo sapiens	90000	*	*Western blotting, unprocessed CFI protein under reducing conditions
MW	Paralabrax nebulifer	155000	*	*gel filtration
SA	Homo sapiens	-999	*	*proteolytic activities of the native and partially deglycosylated forms analyzed, similar activities against complement component C3 indicated, charged glycans of complement factor I do not influence cofactor-substrate binding properties
SA	Mus musculus	-999	*	*complement component C3 level measured in plasma, glomerular complement component C3 staining and complement profile in mice with deficiency of complement factor I indicated
SA	Homo sapiens	-999	*	*hemolytic complement activity test performed, plasma levels and capability to degrade complement components C4b and C3b analyzed in wild-type and mutant protein, kinetics shown, no major differences between mutant and wild-type protein identified
SA	Homo sapiens	-999	*	*keratinocytes stimulated with IFN-gamma (10-1000 U/ml), IL-1alpha (25-200 U/ml), IL-6 (250-1000 U/ml), TNF-alpha (100-1000 U/ml) or TGF-beta1, presence of complement factor I analyzed by monitoring cleavage of complement component C3b, assay with radiolabelled purified complement component C3b
SA	Homo sapiens	-999	*	*presence of complement factor I analyzed by RT-PCR and by monitoring cleavage of complemement components C3b and C4b, assay described, protein concentrations determined by ELISA; presence of complement factor I analyzed by RT-PCR and by monitoring cleavage of complement components C3b and C4b, assay described, protein concentrations determined by ELISA, complement-dependent lysis of non-small cell lung cancer cells analyzed; presence of complement factor I analyzed by RT-PCR and by monitoring cleavage of the complement components C3b and C4b, assay described, protein concentrations determined by ELISA, complement-dependent lysis of non-small cell lung cancer cells analyzed
SA	Homo sapiens	-999	*	*assay of complement component C3b and Cb4 cofactor function and endpoint assay described, complement component C3b and Cb4 cofactor function of M120I, G243D and R388H correspond to those of unmodified proteins, 30% activity retained in R299W mutants, no activity in the mutants D501N, D506V and I322T observed
SA	Homo sapiens	-999	*	*
